Quick Answer
ZIMMER BIOMET HOLDINGS, INC. reported Operating Income of $1.10 billion for fiscal year 2025.
ZIMMER BIOMET HOLDINGS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $1.10B | -14.6% |
| 2024 | $1.29B | +0.6% |
| 2023 | $1.28B | +83.5% |
| 2022 | $696.30M | -19.1% |
| 2021 | $860.30M | +935.3% |
| 2020 | $83.10M | -92.7% |
| 2019 | $1.14B | +3265.4% |
| 2018 | $33.80M | -95.8% |
| 2017 | $799.30M | -2.7% |
| 2016 | $821.10M | +75.7% |
| 2015 | $467.30M | -55.0% |
| 2014 | $1.04B | -2.9% |
| 2013 | $1.07B | +2.0% |
| 2012 | $1.05B | +2.3% |
| 2011 | $1.02B | +11.7% |
| 2010 | $916.70M | -10.0% |
| 2009 | $1.02B | -6.5% |
| 2008 | $1.09B | -3.3% |
| 2007 | $1.13B | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $351.30M | +25.7% | +17.1% |
| June 30, 2025 | $300.00M | -14.6% | +2.6% |
| March 31, 2025 | $292.30M | +9.9% | +4.6% |
| September 30, 2024 | $279.50M | +4.8% | -20.4% |
| June 30, 2024 | $351.30M | +6.6% | +32.1% |
| March 31, 2024 | $265.90M | -18.8% | -0.3% |
| September 30, 2023 | $266.60M | +8.7% | -19.1% |
| June 30, 2023 | $329.60M | +17.3% | +0.7% |
- ZIMMER BIOMET HOLDINGS, INC. showed a decrease of -14.6% in Operating Income compared to the prior fiscal year.
- Over the 2007–2025 period, ZIMMER BIOMET HOLDINGS, INC.’s operating income has declined by 2.6% (from $1.13 billion to $1.10 billion).
- The most recent figure is from ZIMMER BIOMET HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: